MOL CANCER THER 潤色咨詢

MOLECULAR CANCER THERAPEUTICS

出版年份:2001 年文章數(shù):3912 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Monthly 自引率:2.9% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量1.76% (2022年為4.22%)
自引率
2.9 %
年文章數(shù)
3912
期刊官網(wǎng)
點擊查看 (點擊次數(shù):17726)
投稿鏈接
點擊查看 (點擊次數(shù):4073次)
作者需知
暫無數(shù)據(jù)
期刊簡介
稿件收錄要求
Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.